Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 25524
Event :4th annual Biosimilars North America

Dates :Wednesday November 15th, 2017 - Thursday November 16th, 2017

Location :Renaissance Woodbridge Hotel
515 US-1
08830 Iselin, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements.
 
This year, the conference will also explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines, the US market access landscape, and biosimilars of orphan drugs.
 
Key highlights include
- A presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance
- A session on complex biosimilars and new technologies from MedImmune
- Momenta Pharmaceuticals will provide strategies to combat legal, policy and commercial obstacles to development and launch.
- Insights on latest development strategies and market access from Fujifilm Diosynth Biotechnologies
- A talk on drug product and formulation development considerations with Oncobiologics
Key speakers include
- Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals Inc
- Cindy Cao, Executive Director & Head of US Regulatory Affairs fo Biopharmaceuticals, Sandoz
- T. Shantha Raju, Senior Director, MedImmune
- Chrys Kokino, Head Global Biologics Commercial, Mylan
- Steinar Madsen, Medical Director, Norwegian Medicines Agency
- Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals
- Hiten Gutka, Principal Scientist Formulation Development - Biosimilar Development, Oncobiologics Inc
- Patrick Robertson, Director, Program Design, FUJIFIlM Diosynth Biotechnologies
 
Booking: https://go.evvnt.com/130541-1 
 
 
Price:
Book by June 30: USD 1599
Book by September 29: USD 1799
Standard: USD 1899
Workshop: USD 499
 
Time: on Wednesday November 15, 2017 at 8:30 am (ends Thursday November 16, 2017 at 5:30 pm)

Location

Map and directions
Conference address :
Renaissance Woodbridge Hotel
515 US-1
08830 Iselin
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

4th annual Biosimilars North America Medicine
biosimilars, interchangeability, innovator, biosimilar commercialization, immunogenicity, pricing, market growth, biobetters
Everyone
-- -- --
English

Other

For more information on 4th annual Biosimilars North America, plsase contactr SMi Group

To display announcer website, obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event